Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Erschienen in: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 4/2010

01.04.2010 | Empfehlung

Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten

Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI)

verfasst von: Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI)

Erschienen in: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Auszug

1 Einleitung und Ziele …
Fußnoten
1
Defizienz und Suppression des Immunsystems werden im Text unter dem Begriff „Immunschwäche“ zusammengefasst.
 
2
Der niedrigste Wert der Leukozyten (Granulozyten) wird als Nadir bezeichnet. Auch die Tendenz (fallende oder steigende Leukozytenzahl) ist beachtenswert.
 
3
28%, wenn die Granulozytenzahl im peripheren Blut unter 0,1×109/l liegt; dies entspricht <100/µl.
 
Literatur
1.
Berner R, Sauter S, Duffner U et al (1998) Bacteremic episodes in pediatric oncologic patients, especially caused by the Streptococcus viridans group. Klin Pediatr 210:256–260
2.
Pizzo PA, Rubin M, Freifeld A, Walsh TJ (1991) The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr 119:679–694PubMed
3.
Chanock S (1993) Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 7:771–793PubMed
4.
Chanock SJ, Pizzo PA (1995) Infection prevention strategies for children with cancer and AIDS: contrasting dilemmas. J Hosp Infect (30 Suppl):197–208
5.
Chanock SJ, Pizzo PA (1997) Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects. Semin Oncol 24:132–140PubMed
6.
Maschmeyer G, Kern WV, Deutsche Gesellschaft für Hämatologie und Onkologie (2004) Infektionen bei hämatologischen und onkologischen Patienten. DGHO Homepage (http://​www.​dgho.​de)
7.
Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100:228–237PubMed
8.
Buchheidt D, Bohme A, Cornely OA et al (2003) Diagnosis and treatment of documented infections in neutropenic patients – recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S127–S132PubMed
9.
Link H, Bohme A, Cornely OA et al (2003) Antimicrobial therapy of unexplained fever in neutropenic patients – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), study group interventional therapy of unexplained fever, Arbeitsgemeinschaft Supportivmaßnahmen in der Onkologie (ASO) Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):S105–S117PubMed
10.
Cosgrove S, Perl TM (2004) Ch. 60, Infection control and prevention in hematopoetic stem cell transplant patients. In: Mayhall C (ed) Hospital epidemiology and infection control. Lippincott Williams & Wilkins, Philadelphia Baltimore New York, pp 1011–1070
11.
Gaur A (2004) Ch. 58, Nosocomial infections in patients with neoplastic diseases. In: Mayhall C (ed) Hospital epidemiology and infection control. Lippincott Williams & Wilkins, Philadelphia Baltimore New York, pp 969–984
12.
Singh N (2004) Ch. 59, nosocomial infections in solid organ transplant recipients. In: Mayhall C (ed) Hospital epidemiology and infection control. Lippincott Williams & Wilkins, Philadelphia Baltimore New York, pp 985–1009
13.
Centers for Disease Control and Prevention (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49:1–125, CE121–127
14.
Slota M, Green M, Farley A et al (2001) The role of gown and glove isolation and strict handwashing in the reduction of nosocomial infection in children with solid organ transplantation. Crit Care Med 29:405–412PubMed
15.
Grigull L, Beier R, Schrauder A et al (2003) Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses 46:441–446PubMed
16.
Lehrnbecher T, Varwig D, Kaiser J et al (2004) Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 18:72–77PubMed
17.
Rousseau A, Morcos M, Amrouche L et al (2004) Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma 45:1293–1296PubMed
18.
Slats AM, Egeler RM, van der Does-van den Berg A et al (2005) Causes of death – other than progressive leukaemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 19:537–544PubMed
19.
Gaur AH, Flynn PM, Shenep JL (2004) Optimum management of pediatric patients with fever and neutropenia. Indian J Pediatr 71:825–835PubMed
20.
Vento S, Cainelli F (2003) Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4:595–604PubMed
21.
Lehrnbecher T, Foster C, Vazquez N et al (1997) Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 19:399–417PubMed
22.
Lehrnbecher T, Laws H (2005) Infektionen in der pädiatrischen Hämatologie und Onkologie. Klin Padiatr 217(Suppl1):3–8
23.
Nourse C, Byrne C, Murphy H et al (2000) Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol Infect 124:53–59PubMed
24.
Nourse C, Murphy H, Byrne C et al (1998) Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 157:20–27PubMed
25.
Smith TL, Pullen GT, Crouse V et al (2002) Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge. Infect Control Hosp Epidemiol 23:239–243PubMed
26.
Gaynes R (2002) Health care-associated bloodstream infections: a change in thinking. Ann Intern Med 137:850–851PubMed
27.
Friedman ND, Kaye KS, Stout JE et al (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797PubMed
28.
Carratala J, Garcia-Vidal C (2008) What is healthcare-associated pneumonia and how is it managed? Curr Opin Infect Dis 21:168–173PubMed
29.
(n a) (2000) Infektionsschutzgesetz. Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz – IfSG). Bundesgesetzblatt 1:1045–1077
30.
Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (2001) Mitteilungen der Kommission für Krankenhaushygiene und Infektionsprävention zur Surveillance (Erfassung und Bewertung) von nosokomialen Infektionen (Umsetzung §23 IfSG). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 44:523–536
31.
Kommission für Krankenhaushygiene und Infektionsprävention (2000) Händehygiene – Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 43:230–233
32.
Kommission für Krankenhaushygiene und Infektionsprävention (2002) Prävention Gefäßkatheter-assoziierter Infektionen – Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 25:907–924
33.
Kommission für Krankenhaushygiene und Infektionsprävention (2000) Prävention der nosokomialen Pneumonie. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 43:302–309
34.
Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut (1999) Empfehlungen zur Prävention und Kontrolle Katheter-assoziierter Harnwegsinfektionen. Bundesgesundheitbl Gesundheitsforsch Gesundheitsschutz 42:806–809
35.
Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut (2000) Anforderungen der Hygiene bei Operationen und anderen invasiven Eingriffen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 43:644–648
36.
Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut (1999) Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen – Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 42:954–958
37.
Kommission für Krankenhaushygiene und Infektionsprävention (2002) Ausbruchsmanagement und strukturiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 45:180–186
38.
Kommission für Krankenhaushygiene und Infektionsprävention (2004) Anforderung an die Hygiene bei der Reinigung und Desinfektion von Flächen. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 47:51–61
39.
Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut (2006) Infektionsprävention in der Zahnheilkunde – Anforderungen an die Hygiene. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:375–394
40.
Exner M, Just HM (2009) Personnel and organizational prerequisites for prevention and control of nosocomial infections. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 52:889–890
41.
Risi GF, Tomascak V (1998) Prevention of infection in the immunocompromised host. Am J Infect Control 26:594–604PubMed
42.
Simon A, Ammann RA, Bode U et al (2008) Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 university hospitals in Germany and Switzerland. BMC Infect Dis E-Pub May 23:70
43.
Hachem R, Raad I (2002) Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 20:1105–1113PubMed
44.
Mirro J Jr, Rao BN, Kumar M et al (1990) A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 25:120–124PubMed
45.
Morrison VA, Peterson BA, Bloomfield CD (1990) Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy. Med Pediatr Oncol 18:209–216PubMed
46.
Raad I (1998) Intravascular-catheter-related infections. Lancet 351:893–898PubMed
47.
Urrea M, Rives S, Cruz O et al (2004) Nosocomial infections among pediatric hematology/oncology patients: results of a prospective incidence study. Am J Infect Control 32:205–208PubMed
48.
Hoff J van, Berg AT, Seashore JH (1990) The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol 8:1255–1262PubMed
49.
Fatkenheuer G, Buchheidt D, Cornely OA et al (2003) Central venous catheter (CVC)-related infections in neutropenic patients – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S149–S157PubMed
50.
Fatkenheuer G, Cornely O, Seifert H (2002) Clinical management of catheter-related infections. Clin Microbiol Infect 8:545–550PubMed
51.
Mermel LA, Farr BM, Sherertz RJ et al (2001) Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 24:180–205PubMed
52.
Jarvis WR (2002) The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think? Infect Control Hosp Epidemiol 23:236–238PubMed
53.
Jarvis WR (2004) Controlling healthcare-associated infections: the role of infection control and antimicrobial use practices. Semin Pediatr Infect Dis 15:30–40PubMed
54.
McCarthy A, Rao JS, Byrne M et al (1998) Central venous catheter infections treated with teicoplanin. Eur J Haematol (Suppl 62):15–17
55.
Farr BM, Salgado CD, Karchmer TB, Sherertz RJ (2001) Can antibiotic-resistant nosocomial infections be controlled? Lancet Infect Dis 1:38–45PubMed
56.
Gaynes R, Edwards R, National Nosocomial Surveillance System (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848–854PubMed
57.
Bodey G, Buckley M, Sathe Y, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340PubMed
58.
Torres HA, Bodey GP, Rolston KV et al (2003) Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 98:86–93PubMed
59.
Catenacci DV, Schiller GJ (2005) Myelodysplasic syndromes: a comprehensive review. Blood Rev 19:301–319PubMed
60.
Dallorso S, Manzitti C, Dodero P et al (2003) Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 70:322–325PubMed
61.
Donadieu J, Leblanc T, Bader Meunier B et al (2005) Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French severe chronic neutropenia study group. Haematologica 90:45–53PubMed
62.
Ferry C, Ouachee M, Leblanc T et al (2005) Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 35:45–50PubMed
63.
Maschmeyer G, Beinert T, Buchheidt D et al (2003) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S118–S126PubMed
64.
Maschmeyer G, Beinert T, Buchheidt D et al (2009) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology. Eur J Cancer 45:2462–2472PubMed
65.
Kontoyiannis DP, Bodey GP (2002) Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 21:161–172PubMed
66.
Kontoyiannis DP, Lionakis MS, Lewis RE et al (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191:1350–1360PubMed
67.
Kontoyiannis DP, Torres HA, Chagua M et al (2004) Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564–569PubMed
68.
Kontoyiannis DP, Vaziri I, Hanna HA et al (2001) Risk factors for candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33:1676–1681PubMed
69.
Lex C, Korholz D, Kohlmuller B et al (2001) Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma – a rationale for tailored supportive care. Support Care Cancer 9:514–521PubMed
70.
Lehrnbecher T (2001) Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases. Klin Padiatr 213(Suppl 1):A103–A105PubMed
71.
American Academy of Pediatrics, Committee on Infectious Diseases (2000) American academy of pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106:362–366
72.
Davidson RN, Wall RA (2001) Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 7:657–660PubMed
73.
Montalembert M de, Lenoir G (2004) Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency. Ann Hematol 83:18–21PubMed
74.
Hasse B, Moll C, Oehy K et al (2005) Anti-infectious prophylaxis after splenectomy: current practice in an eastern region of Switzerland. Swiss Med Wkly 135:291–296PubMed
75.
Bow EJ (1998) Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. J Antimicrob Chemother 41(Suppl D):1–5PubMed
76.
Cornely OA, Ullmann AJ, Karthaus M (2004) Opportunistic infections after treatment with monoclonal antibodies. Wien Med Wochenschr 154:209–217PubMed
77.
Dai MS, Chao TY, Kao WY et al (2004) Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Ann Hematol 83:769–774PubMed
78.
Endo T, Sakai T, Fujimoto K et al (2001) A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplant 27:433–436PubMed
79.
Lin PC, Poh SB, Lee MY et al (2005) Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients. Int J Hematol 81:349–351PubMed
80.
Pelizzari AM, Motta M, Cariani E et al (2004) Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies. Hematol J 5:325–328PubMed
81.
Rossi G (2003) Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy. Leuk Lymphoma 44:759–766PubMed
82.
Rossi G, Pelizzari A, Motta M, Puoti M (2001) Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. Br J Haematol 115:58–62PubMed
83.
Yeo W, Chan PK, Ho WM et al (2004) Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J Clin Oncol 22:927–934PubMed
84.
Akiyama H, Yoshinaga H, Tanaka T et al (1997) Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplantation Team. Bone Marrow Transplant 20:993–995PubMed
85.
Widell A, Christensson B, Wiebe T et al (1999) Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Intern Med 130:130–134PubMed
86.
Rieske K, Domula M, Liebert UG et al (1998) Clinical aspects and epidemiology of hepatitis C in immunosuppressed children with mostly oncologic diseases. Klin Padiatr 210:274–278PubMed
87.
Styczynski J, Wysocki M, Koltan S, Kurylak A (2001) Epidemiologic aspects and preventive strategy of hepatitis B and C viral infections in children with cancer. Pediatr Infect Dis J 20:1042–1049PubMed
88.
Knoll A, Helmig M, Peters O, Jilg W (2001) Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab Invest 81:251–262PubMed
89.
Weinstock DM, Rogers M, Eagan J et al (2002) Nosocomial central venous catheter infections among patients with different types of cancer. Infect Control Hosp Epidemiol 23:234–235PubMed
90.
Weisman LE (2004) Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient. Curr Opin Infect Dis 17:237–241PubMed
91.
Viscoli C, Castagnola E, Giacchino M et al (1999) Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive therapy group-infectious diseases section. Eur J Cancer 35:770–774PubMed
92.
Wolf HH, Leithauser M, Maschmeyer G et al (2008) Central venous catheter-related infections in hematology and oncology: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 87:863–876PubMed
93.
Simon A, Ammann RA, Wiszniewsky G et al (2008) Taurolidine-citrate lock solution (TauroLockTM) significantly reduces CVAD-associated Gram positive infections in paediatric cancer patients. BMC Infectious Diseases 8:102PubMed
94.
Simon A, Beutel K, Hasan C, Bode U (2005) Evidence-based recommendation for the management of long-term central venous access devices in pediatric patients. German Society of Pediatric Hematology and Oncology (GPOH) Bonn
95.
Simon A, Bode U, Beutel K (2006) Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect 12:606–620PubMed
96.
O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. The hospital infection control practices advisory committee, center for disese control and prevention, u.s. Pediatrics 110:e51
97.
Raad I (2000) Management of intravascular catheter-related infections. J Antimicrob Chemother 45:267–270PubMed
98.
Sitges-Serra A, Girvent M (1999) Catheter-related bloodstream infections. World J Surg 23:589–595PubMed
99.
Blot F, Nitenberg G, Brun-Buisson C (2000) New tools in diagnosing catheter-related infections. Support Care Cancer 8:287–292PubMed
100.
Bouza E, Burillo A, Munoz P (2002) Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8:265–274PubMed
101.
Longuet P, Douard MC, Arlet G et al (2001) Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis 32:1776–1783PubMed
102.
Lacey S, Want SV (1991) Pseudomonas pickettii infections in a paediatric oncology unit. J Hosp Infect 17:45–51PubMed
103.
Marroni M, Pasticci MB, Pantosti A et al (2003) Outbreak of infusion-related septicemia by Ralstonia pickettii in the oncology department. Tumori 89:575–576PubMed
104.
Pegues DA, Carson LA, Anderson RL et al (1993) Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis 16:407–411PubMed
105.
Attar A, Messing B (2001) Evidence-based prevention of catheter infection during parenteral nutrition. Curr Opin Clin Nutr Metab Care 4:211–218PubMed
106.
Ball PA (2003) Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care 6:319–325PubMed
107.
Christensen ML, Hancock ML, Gattuso J et al (1993) Parenteral nutrition associated with increased infection rate in children with cancer. Cancer 72:2732–2738PubMed
108.
Hodge D, Puntis JW (2002) Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatal Ed 87:F21–F24PubMed
109.
Lenssen P, Bruemmer BA, Bowden RA et al (1998) Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr 67:927–933PubMed
110.
Moukarzel AA, Haddad I, Ament ME et al (1994) 230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg 29:1323–1327PubMed
111.
Pollack PF, Kadden M, Byrne WJ et al (1981) 100 patient years‘ experience with the Broviac silastic catheter for central venous nutrition. JPEN J Parenter Enteral Nutr 5:32–36PubMed
112.
Puntis JW, Holden CE, Smallman S et al (1991) Staff training: a key factor in reducing intravascular catheter sepsis. Arch Dis Child 66:335–337PubMed
113.
Moreira BM, Leobons MB, Pellegrino FL et al (2005) Ralstonia pickettii and Burkholderia cepacia complex bloodstream infections related to infusion of contaminated water for injection. J Hosp Infect 60:51–55PubMed
114.
Bahles S, Schnitzler N (2000) Infektionsschutzgesetz – Kommentar und Vorschriftensammlung. Kohlhammer, Stuttgart Berlin Köln
115.
Gastmeier P, Stamm-Balderjahn S, Hansen S et al (2005) How outbreaks can contribute to prevention of nosocomial infection: analysis of 1,022 outbreaks. Infect Control Hosp Epidemiol 26:357–361PubMed
116.
Pusch D, Oh DY, Wolf S et al (2005) Detection of enteric viruses and bacterial indicators in German environmental waters. Arch Virol 150:929–947PubMed
117.
Simon A, Schildgen O, Maria Eis-Hubinger A et al (2006) Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol 41:693–699PubMed
118.
Rayani A, Bode U, Habas E et al (2007) Rotavirus infections in paediatric oncology patients: a matched-pairs analysis. Scand J Gastroenterol 42:81–87PubMed
119.
Simon A, Bode U, Fleischhack G, Kramer M (2005) Surveillance of nosocomial infections in pediatric cancer patients. Am J Infect Control 33:611PubMed
120.
Simon A, Khurana K, Wilkesmann A et al (2006) Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 209:317–324PubMed
121.
Hall CB (2000) Nosocomial respiratory syncytial virus infections: the „Cold War“ has not ended. Clin Infect Dis 31:590–596PubMed
122.
Eisen D, Essell J, Broun ER (1997) Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 16:265–272PubMed
123.
Barker GJ (1999) Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 7:17–20PubMed
124.
Solomon CS, Shaikh AB, Arendorf TM (1995) An efficacious oral health care protocol for immunocompromised patients. Spec Care Dentist 15:228–233PubMed
125.
Philpott-Howard J (1996) Prevention of fungal infections in hematology patients. Infect Control Hosp Epidemiol 17:545–551PubMed
126.
Patel R, Paya CV (1997) Infections in solid-organ transplant recipients. Clin Microbiol Rev 10:86–124PubMed
127.
Hicks KL, Chemaly RF, Kontoyiannis DP (2003) Common community respiratory viruses in patients with cancer: more than just „common colds“. Cancer 97:2576–2587PubMed
128.
Couch RB, Englund JA, Whimbey E (1997) Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 102:2–9; discussion 25–26PubMed
129.
Hirsch HH, Steffen I, Francioli P, Widmer AF (2006) Respiratory syncytial virus infections: measures in immunocompromised patients. Schweiz Rundsch Med Prax 95:61–66
130.
Burke JP (2003) Infection control – a problem for patient safety. N Engl J Med 348:651–656PubMed
131.
Pittet D (2000) Improving compliance with hand hygiene in hospitals. Infect Control Hosp Epidemiol 21:381–386PubMed
132.
Harbarth S, Sudre P, Dharan S et al (1999) Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 20:598–603PubMed
133.
Boulay BR, Murray CJ, Ptak J et al (2006) An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 27:92–95PubMed
134.
Nair D, Gupta N, Kabra S et al (1999) Salmonella senftenberg: a new pathogen in the burns ward. Burns 25:723–727PubMed
135.
Blok HE, Troelstra A, Kamp-Hopmans TE et al (2003) Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 24:679–685PubMed
136.
Chuman Y, Takata T, Sameshima H et al (2003) Campylobacter fetus bacteremia in a patient with adult T cell leukemia. Clin Infect Dis 36:1497–1498PubMed
137.
Monno R, Rendina M, Ceci G et al (2004) Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature. New Microbiol 27:281–285PubMed
138.
Monselise A, Blickstein D, Ostfeld I et al (2004) A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature. Eur J Clin Microbiol Infect Dis 23:718–721PubMed
139.
Shehabi AA, Abu-Al-Soud W, Mahafzah A et al (2004) Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than cystic fibrosis. Scand J Infect Dis 36:174–178PubMed
140.
Remington J, Schimpff SC (1981) Please don’t eat the salads. N Engl J Med 304:433–435PubMed
141.
Exner M, Kramer A, Lajoie L et al (2005) Prevention and control of health care-associated waterborne infections in health care facilities. Am J Infect Control 33:S26–S40PubMed
142.
Wiesmayr S, Tabarelli W, Stelzmueller I et al (2005) Listeria meningitis in transplant recipients. Wien Klin Wochenschr 117:229–233PubMed
143.
Rivero GA, Torres HA, Rolston KV, Kontoyiannis DP (2003) Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis 47:393–398PubMed
144.
Mora J, White M, Dunkel IJ (1998) Listeriosis in pediatric oncology patients. Cancer 83:817–820PubMed
145.
Ponticelli C, Campise MR (2005) Neurological complications in kidney transplant recipients. J Nephrol 18:521–528PubMed
146.
Willems RJ, Top J, Santen M van et al (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11:821–828PubMed
147.
Moellering RC Jr (1998) Vancomycin-resistant enterococci. Clin Infect Dis 26:1196–1199PubMed
148.
Bouakline A, Lacroix C, Roux N et al (2000) Fungal contamination of food in hematology units. J Clin Microbiol 38:4272–4273PubMed
149.
Eccles NK, Scott GM (1992) Aspergillus in pepper. Lancet 339:618PubMed
150.
Wilson C, Dettenkofer M, Jonas D, Daschner FD (2004) Pathogen growth in herbal teas used in clinical settings: a possible source of nosocomial infection? Am J Infect Control 32:117–119PubMed
151.
Hauer T, Jonas D, Dettenkofer M, Daschner FD (1999) Tea as a source of Acinetobacter baumannii ventilator-associated pneumonia? Infect Control Hosp Epidemiol 20:594PubMed
152.
Schmid I, Albert M, Stachel D, Simon A (2008) Nahrungsmittelrestriktionen zur Infektionsprävention bei Kindern mit Krebserkrankung: Was ist gesichert und was ist sinnvoll? Hygiene & Medizin 33:16–24
153.
Todd J, Schmidt M, Christain J, Williams R (1999) The low-bacteria diet for immunocompromised patients. Reasonable prudence or clinical superstition? Cancer Pract 7:205–207PubMed
154.
Dols CL, Bowers JM, Copfer AE (2001) Preventing food- and water-borne illnesses. Am J Nurs 101:24AA–24HHPubMed
155.
Smith LH, Besser SG (2000) Dietary restrictions for patients with neutropenia: a survey of institutional practices. Oncol Nurs Forum 27:515–520PubMed
156.
Lau SK, Woo PC, Leung KW, Yuen KY (2002) Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 21:127–129PubMed
157.
Nassauer A (2006) Anforderungen an die Hygiene bei der Lebensmittelversorgung und ihre Qualität – Hinweise und Kommentierung. Epid Bull 29:228–229
158.
French MR, Levy-Milne R, Zibrik D (2001) A survey of the use of low microbial diets in pediatric bone marrow transplant programs. J Am Diet Assoc 101:1194–1198PubMed
159.
Mank A, Lelie H van der (2003) Is there still an indication for nursing patients with prolonged neutropenia in protective isolation? An evidence-based nursing and medical study of 4 years experience for nursing patients with neutropenia without isolation. Eur J Oncol Nurs 7:17–23PubMed
160.
Dadd G, McMinn P, Monterosso L (2003) Protective isolation in hemopoietic stem cell transplants: a review of the literature and single institution experience. J Pediatr Oncol Nurs 20:293–300PubMed
161.
Fenelon L (1998) Strategies for prevention of infection in short-duration neutropenia. Infect Control Hosp Epidemiol 19:590–592PubMed
162.
Fenelon LE (1995) Protective isolation: who needs it? J Hosp Infect (Suppl 30):218–222
163.
Moody K, Charlson ME, Finlay J (2002) The neutropenic diet: what’s the evidence? J Pediatr Hematol Oncol 24:717–721PubMed
164.
Pizzo PA, Purvis DS, Waters C (1982) Microbiologic evaluation of food items. J Am Diet Assoc 81:272–279PubMed
165.
Rose JB (1997) Environmental ecology of Cryptosporidium and public health implications. Annu Rev Public Health 18:135–161PubMed
166.
Leclerc H, Schwartzbrod L, Dei-Cas E (2002) Microbial agents associated with waterborne diseases. Crit Rev Microbiol 28:371–409PubMed
167.
Hall J, Hodgson G, Kerr KG (2004) Provision of safe potable water for immunocompromised patients in hospital. J Hosp Infect 58:155–158PubMed
168.
Engelhart S, Krizek L, Glasmacher A et al (2002) Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 52:93–98PubMed
169.
Wilkinson FH, Kerr KG (1998) Bottled water as a source of multi-resistant Stenotrophomonas and Pseudomonas species for neutropenic patients. Eur J Cancer Care (Engl) 7:12–14
170.
Bert F, Maubec E, Bruneau B et al (1998) Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit. J Hosp Infect 39:53–62PubMed
171.
Buttery JP, Alabaster SJ, Heine RG et al (1998) Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. Pediatr Infect Dis J 17:509–513PubMed
172.
Muscarella LF (2004) Contribution of tap water and environmental surfaces to nosocomial transmission of antibiotic-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 25:342–345PubMed
173.
Oren I, Zuckerman T, Avivi I et al (2002) Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control. Bone Marrow Transplant 30:175–179PubMed
174.
Tablan OC, Anderson LJ, Besser R et al (2004) Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53:1–36PubMed
175.
Greenberg D, Chiou CC, Famigilleti R et al (2006) Problem pathogens: paediatric legionellosis – implications for improved diagnosis. Lancet Infect Dis 6:529–535PubMed
176.
O’Neill E, Humphreys H (2005) Surveillance of hospital water and primary prevention of nosocomial legionellosis: what is the evidence? J Hosp Infect 59:273–279
177.
Kappstein I, Grundmann H, Hauer T, Niemeyer C (2000) Aerators as a reservoir of Acinetobacter junii: an outbreak of bacteraemia in paediatric oncology patients. J Hosp Infect 44:27–30PubMed
178.
Nasser RM, Rahi AC, Haddad MF et al (2004) Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect Control Hosp Epidemiol 25:231–239PubMed
179.
Perola O, Nousiainen T, Suomalainen S et al (2002) Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. J Hosp Infect 50:196–201PubMed
180.
Sakhnini E, Weissmann A, Oren I (2002) Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am J Med Sci 323:269–272PubMed
181.
Kline S, Cameron S, Streifel A et al (2004) An outbreak of bacteremias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol 25:1042–1049PubMed
182.
Kauppinen J, Nousiainen T, Jantunen E et al (1999) Hospital water supply as a source of disseminated Mycobacterium fortuitum infection in a leukemia patient. Infect Control Hosp Epidemiol 20:343–345PubMed
183.
Conger NG, O’Connell RJ, Laurel VL et al (2004) Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 25:1050–1055PubMed
184.
Exner M, Gornik V (2004) Parasitic zoonoses transmitted by drinking water. Giardiasis and cryptosporidiosis. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 47:698–704
185.
Hajjeh RA, Warnock DW (2001) Counterpoint: invasive aspergillosis and the environment – rethinking our approach to prevention. Clin Infect Dis 33:1549–1552PubMed
186.
Anaissie EJ, Costa SF (2001) Nosocomial aspergillosis is waterborne. Clin Infect Dis 33:1546–1548PubMed
187.
Anaissie EJ, Kuchar RT, Rex JH et al (2001) Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 33:1871–1878PubMed
188.
Anaissie EJ, Stratton SL, Dignani MC et al (2002) Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis 35:E86–E88PubMed
189.
Anaissie EJ, Stratton SL, Dignani MC et al (2003) Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. Blood 101:2542–2546PubMed
190.
Anaissie EJ, Stratton SL, Dignani MC et al (2002) Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 34:780–789PubMed
191.
Evans MR, Ribeiro CD, Salmon RL (2003) Hazards of healthy living: bottled water and salad vegetables as risk factors for Campylobacter infection. Emerg Infect Dis 9:1219–1225PubMed
192.
Tatchou-Nyamsi-Konig JA, Moreau A, Federighi M, Block JC (2007) Behaviour of Campylobacter jejuni in experimentally contaminated bottled natural mineral water. J Appl Microbiol 103:280–288PubMed
193.
Centers for Disease Control and Prevention Cryptosporidiosis. http://​www.​cdc.​gov/​crypto/​
194.
Aumeran C, Paillard C, Robin F et al (2007) Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect 65:47–53PubMed
195.
Ferroni A, Nguyen L, Pron B et al (1998) Outbreak of nosocomial urinary tract infections due to Pseudomonas aeruginosa in a paediatric surgical unit associated with tap-water contamination. J Hosp Infect 39:301–307PubMed
196.
Horcajada JP, Martinez JA, Alcon A et al (2006) Acquisition of multidrug-resistant serratia marcescens by critically Ill patients who consumed tap water during receipt of oral medication. Infect Control Hosp Epidemiol 27:774–777PubMed
197.
Verweij PE, Meis JF, Christmann V et al (1998) Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect 120:251–256PubMed
198.
Rogues AM, Boulestreau H, Lasheras A et al (2007) Contribution of tap water to patient colonisation with Pseudomonas aeruginosa in a medical intensive care unit. J Hosp Infect 67:72–78PubMed
199.
Trautmann M, Lepper PM, Haller M (2005) Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am J Infect Control 33:S41–S49PubMed
200.
Valles J, Mariscal D, Cortes P et al (2004) Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia. Intensive Care Med 30:1768–1775PubMed
201.
Reuter S, Sigge A, Wiedeck H, Trautmann M (2002) Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets. Crit Care Med 30:2222–2228PubMed
202.
Stout JE, Muder RR, Mietzner S et al (2007) Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations. Infect Control Hosp Epidemiol 28:818–824PubMed
203.
Sabria M, Modol JM, Garcia-Nunez M et al (2004) Environmental cultures and hospital-acquired Legionnaires‘ disease: a 5-year prospective study in 20 hospitals in Catalonia, Spain. Infect Control Hosp Epidemiol 25:1072–1076PubMed
204.
Corso PS, Kramer MH, Blair KA et al (2003) Cost of illness in the 1993 waterborne Cryptosporidium outbreak, Milwaukee, Wisconsin. Emerg Infect Dis 9:426–431PubMed
205.
Hoxie NJ, Davis JP, Vergeront JM et al (1997) Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am J Public Health 87:2032–2035PubMed
206.
Trautmann M, Bauer C, Schumann C et al (2006) Common RAPD pattern of Pseudomonas aeruginosa from patients and tap water in a medical intensive care unit. Int J Hyg Environ Health 209:325–331PubMed
207.
Vianelli N, Giannini MB, Quarti C et al (2006) Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters. Haematologica 91:983–985PubMed
208.
Rechenburg A, Engelhart S, Exner M (2001) Spring water in hospitals – an alternative drinking water concerns with processed mineral water? Dtsch Med Wochenschr 126:50PubMed
209.
Vonberg RP, Eckmanns T, Bruderek J et al (2005) Use of terminal tap water filter systems for prevention of nosocomial legionellosis. J Hosp Infect 60:159–162PubMed
210.
Vonberg RP, Rotermund-Rauchenberger D, Gastmeier P (2005) Reusable terminal tap water filters for nosocomial legionellosis prevention. Ann Hematol 84:403–405PubMed
211.
Adler S, Eikenberg M, Daschner F (2007) Drinking water in hospitals: water coolers vs. drinking water systems vs. mineral water in bottles. Dtsch Med Wochenschr 132:281–284PubMed
212.
Papadopoulou A, MacDonald A, Williams MD et al (1997) Enteral nutrition after bone marrow transplantation. Arch Dis Child 77:131–136PubMed
213.
Zamberlan da Silva ME, Santana RG, Guilhermetti M et al (2008) Comparison of the bacteriological quality of tap water and bottled mineral water. Int J Hyg Environ Health 211:504–509
214.
Eckmanns T, Oppert M, Martin M et al (2008) An outbreak of hospital-acquired Pseudomonas aeruginosa infection caused by contaminated bottled water in intensive care units. Clin Microbiol Infect 14:454–458PubMed
215.
Monforte V, Roman A, Gavalda J et al (2001) Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant 20:1274–1281PubMed
216.
Manuel RJ, Kibbler CC (1998) The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 39:95–109PubMed
217.
Perdelli F, Cristina ML, Sartini M et al (2006) Fungal contamination in hospital environments. Infect Control Hosp Epidemiol 27:44–47PubMed
218.
Burwen DR, Lasker BA, Rao N et al (2001) Invasive aspergillosis outbreak on a hematology-oncology ward. Infect Control Hosp Epidemiol 22:45–48PubMed
219.
Iwen PC, Davis JC, Reed EC et al (1994) Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol 15:303–306PubMed
220.
Loo VG, Bertrand C, Dixon C et al (1996) Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 17:360–364PubMed
221.
Barnes RA, Rogers TR (1989) Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect 14:89–94PubMed
222.
Thio CL, Smith D, Merz WG et al (2000) Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 21:18–23PubMed
223.
Engelhart S, Hanfland J, Glasmacher A et al (2003) Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions. J Hosp Infect 54:300–304PubMed
224.
Anderson K, Morris G, Kennedy H et al (1996) Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 51:256–261PubMed
225.
Rhame FS, Streifel AJ, Kersey JH Jr, McGlave PB (1984) Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med 76:42–52PubMed
226.
(n a) Centers for Diseases Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49:1–125, CE121–127
227.
Vonberg RP, Gastmeier P (2006) Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63:246–254PubMed
228.
Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366PubMed
229.
Schwartz S, Ruhnke M, Ribaud P et al (2005) Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 106:2641–2645PubMed
230.
Simon A, Ammann RA, Bode U et al (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70PubMed
231.
Muhlemann K, Wenger C, Zenhausern R, Tauber MG (2005) Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia 19:545–550PubMed
232.
Oren I, Goldstein N (2002) Invasive pulmonary aspergillosis. Curr Opin Pulm Med 8:195–200PubMed
233.
Oren I, Haddad N, Finkelstein R, Rowe JM (2001) Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 66:257–262PubMed
234.
Passweg JR, Rowlings PA, Atkinson KA et al (1998) Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 21:1231–1238PubMed
235.
Marr KA, Carter RA, Boeckh M et al (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–4366PubMed
236.
Marr KA, Carter RA, Crippa F et al (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34:909–917PubMed
237.
Groll AH, Kurz M, Schneider W et al (1999) Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 42:431–442PubMed
238.
Groll AH, Ritter J, Muller FM (2001) Prevention of fungal infections in children and adolescents with cancer. Klin Padiatr 213(Suppl 1):A50–A68PubMed
239.
Herbrecht R, Natarajan-Amé S, Letscher-Bru V, Canuet M (2004) Invasive pulmonary aspergillosis. Semin Respir Crit Care Med 25:191–202PubMed
240.
Bille J, Marchetti O, Calandra T (2005) Changing face of health-care associated fungal infections. Curr Opin Infect Dis 18:314–319PubMed
241.
Iwen PC, Reed EC, Armitage JO et al (1993) Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 14:131–139PubMed
242.
Sherertz RJ, Belani A, Kramer BS et al (1987) Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 83:709–718PubMed
243.
Leenders AC, Belkum A van, Behrendt M et al (1999) Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection. J Clin Microbiol 37:1752–1757PubMed
244.
Alberti C, Bouakline A, Ribaud P et al (2001) Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect 48:198–206PubMed
245.
Cornet M, Levy V, Fleury L et al (1999) Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 20:508–513PubMed
246.
Streifel AJ (2002) In with the good air. Infect Control Hosp Epidemiol 23:488–490PubMed
247.
Eckmanns T, Ruden H, Gastmeier P (2006) The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review. J Infect Dis 193:1408–1418PubMed
248.
Hahn T, Cummings KM, Michalek AM et al (2002) Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol 23:525–531PubMed
249.
Humphreys H (2004) Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence? J Hosp Infect 56:93–100; quiz 163PubMed
250.
Hayes-Lattin B, Leis JF, Maziarz RT (2005) Isolation in the allogeneic transplant environment: how protective is it? Bone Marrow Transplant 36:373–381PubMed
251.
Nosari A, Oreste P, Cairoli R et al (2001) Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 68:231–236PubMed
252.
Sipsas NV, Kontoyiannis DP (2006) Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis 42:1584–1591PubMed
253.
Benjamin DK Jr, Miller WC, Bayliff S et al (2002) Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 21:227–234PubMed
254.
Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130PubMed
255.
Hota B (2004) Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 39:1182–1189PubMed
256.
Muto CA, Jernigan JA, Ostrowsky BE et al (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–386PubMed
257.
Neely AN (2000) A survey of gram-negative bacteria survival on hospital fabrics and plastics. J Burn Care Rehabil 21:523–527PubMed
258.
Neely AN, Maley MP (2000) Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38:724–726PubMed
259.
Neely AN, Maley MP (2001) Dealing with contaminated computer keyboards and microbial survival. Am J Infect Control 29:131–132PubMed
260.
Neely AN, Sittig DF (2002) Basic microbiologic and infection control information to reduce the potential transmission of pathogens to patients via computer hardware. J Am Med Inform Assoc 9:500–508PubMed
261.
Engelhart E, Fischnaller E, Simon A et al (2008) Mikrobielle Kontamination von Computerbedienungsoberflächen (Tastatur, Maus) in einem Universitätsklinikum unter Alltagsbedingungen. Hygiene & Medizin 33:504–507
262.
Blanc DS, Nahimana I, Petignat C et al (2004) Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med 30:1964–1968PubMed
263.
Halabi M, Wiesholzer-Pittl M, Schoberl J, Mittermayer H (2001) Non-touch fittings in hospitals: a possible source of Pseudomonas aeruginosa and Legionella spp. J Hosp Infect 49:117–121PubMed
264.
Hota S, Hirji Z, Stockton K et al (2009) Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol 30:25–33PubMed
265.
Arnouts PJ, Ramael MR, Ysebaert DK et al (1991) Legionella pneumophila peritonitis in a kidney transplant patient. Scand J Infect Dis 23:119–122PubMed
266.
Gahrn-Hansen B, Uldum SA, Schmidt J et al (1995) Nosocomial Legionella pneumophila infection in a nephrology department. Ugeskr Laeger 157:590–594PubMed
267.
Kusnetsov J, Torvinen E, Perola O et al (2003) Colonization of hospital water systems by legionellae, mycobacteria and other heterotrophic bacteria potentially hazardous to risk group patients. Apmis 111:546–556PubMed
268.
Sax H, Dharan S, Pittet D (2002) Legionnaires‘ disease in a renal transplant recipient: nosocomial or home-grown? Transplantation 74:890–892PubMed
269.
Gerba CP, Wallis C, Melnick JL (1975) Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 30:229–237PubMed
270.
Barker J, Bloomfield SF (2000) Survival of Salmonella in bathrooms and toilets in domestic homes following salmonellosis. J Appl Microbiol 89:137–144PubMed
271.
Hemsworth S, Pizer B (2006) Pet ownership in immunocompromised children – a review of the literature and survey of existing guidelines. Eur J Oncol Nurs 10:117–127PubMed
272.
Plaut M, Zimmerman EM, Goldstein RA (1996) Health hazards to humans associated with domestic pets. Annu Rev Public Health 17:221–245PubMed
273.
Krauss H, WA, Appel M, Enders B et al (2004) Zoonosen. Deutscher Ärzteverlag, Köln
274.
Clare A, Dykewicz H, Jonathan F (2000) Kaplan in collaboration with the Guidelines Working Group Members from CDC tIDSoA, and the American Dociety of Blood and Marrow Transplantation. Guidelines für preventing opportunistic infections among hematopoietic stem cell transplant recipients – recommendations of CDC, the Infectious Disease Society of America and the American Society of Blood and Marrow Transplantation. MMWR 49:1–128
275.
Kotton CN (2007) Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 44:857–866PubMed
276.
Nosanchuk JD, Shoham S, Fries BC et al (2000) Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med 132:205–208PubMed
277.
Shrestha RK, Stoller JK, Honari G et al (2004) Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel. Respir Care 49:606–608PubMed
278.
Juckett G (1997) Pets and parasites. Am Fam Physician 56:1763–1774, 1777–1778PubMed
279.
Marcus LC, Marcus E (1998) Nosocomial zoonoses. N Engl J Med 338:757–759PubMed
280.
Robertson ID, Irwin PJ, Lymbery AJ, Thompson RC (2000) The role of companion animals in the emergence of parasitic zoonoses. Int J Parasitol 30:1369–1377PubMed
281.
Goldstein EJ (1991) Household pets and human infections. Infect Dis Clin North Am 5:117–130PubMed
282.
Tan JS (1997) Human zoonotic infections transmitted by dogs and cats. Arch Intern Med 157:1933–1943PubMed
283.
Krause PJ, Gross PA, Barrett TL et al (1994) Quality standard for assurance of measles immunity among health care workers. The Infectious Diseases Society of America. Infect Control Hosp Epidemiol 15:193–199PubMed
284.
Uckay I, Sax H, Hugonnet S et al (2005) Consequences of an unsufficient range of immunity in „pediatric“ infectious diseases – example with measles. Ther Umsch 62:679–684PubMed
285.
Poland GA, Tosh P, Jacobson RM (2005) Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 23:2251–2255PubMed
286.
Russell ML, Henderson EA (2003) The measurement of influenza vaccine coverage among health care workers. Am J Infect Control 31:457–461PubMed
287.
McIntosh ED (2005) Paediatric infections: prevention of transmission and disease-implications for adults. Vaccine 23:2087–2089PubMed
288.
Tennenberg AM, Brassard JE, Van Lieu J, Drusin LM (1997) Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits. Infect Control Hosp Epidemiol 18:405–411PubMed
289.
Weber DJ, Rutala WA, Hamilton H (1996) Prevention and control of varicella-zoster infections in healthcare facilities. Infect Control Hosp Epidemiol 17:694–705PubMed
290.
Ständige Impfkommission (STIKO) am Robert Koch-Institut (2005) Hinweise zu Impfungen bei Patienten mit Immundefizienz. Epidemiol Bull 39:1–2
291.
Maschmeyer G, Neuburger S, Fritz L et al (2009) A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. Ann Oncol 20:1560–1564PubMed
292.
Langley JM, Hanakowski M, Bortolussi R (1994) Demand for isolation beds in a pediatric hospital. Am J Infect Control 22:207–211PubMed
293.
Pottecher B, Herbrecht R, Blanc-Vincent MP et al (2000) Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Federation Nationale des Centres de Lutte Contre le Cancer. Bull Cancer 87:557–591PubMed
294.
Salminen MK, Rautelin H, Tynkkynen S et al (2006) Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 42:e35–e44PubMed
295.
Land MH, Rouster-Stevens K, Woods CR et al (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115:178–181PubMed
296.
Kunz AN, Fairchok MP, Noel JM (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 116:517; author reply 517–518PubMed
297.
Cannon JP, Lee TA, Bolanos JT, Danziger LH (2005) Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24:31–40PubMed
298.
Arpi M, Vancanneyt M, Swings J, Leisner JJ (2003) Six cases of Lactobacillus bacteraemia: identification of organisms and antibiotic susceptibility and therapy. Scand J Infect Dis 35:404–408PubMed
299.
Carretto E, Barbarini D, Marzani FC et al (2001) Catheter-related bacteremia due to Lactobacillus rhamnosus in a single-lung transplant recipient. Scand J Infect Dis 33:780–782PubMed
300.
Schlegel L, Lemerle S, Geslin P (1998) Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis 17:887–888PubMed
301.
Cooper CD, Vincent A, Greene JN et al (1998) Lactobacillus bacteremia in febrile neutropenic patients in a cancer hospital. Clin Infect Dis 26:1247–1248PubMed
302.
Munoz P, Bouza E, Cuenca-Estrella M et al (2005) Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 40:1625–1634PubMed
303.
Herbrecht R, Nivoix Y (2005) Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clin Infect Dis 40:1635–1637PubMed
304.
Enache-Angoulvant A, Hennequin C (2005) Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 41:1559–1568PubMed
305.
Cassone M, Serra P, Mondello F et al (2003) Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 41:5340–5343PubMed
306.
Cesaro S, Chinello P, Rossi L, Zanesco L (2000) Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 8:504–505PubMed
307.
Fiore NF, Conway JH, West KW, Kleiman MB (1998) Saccharomyces cerevisiae infections in children. Pediatr Infect Dis J 17:1177–1179PubMed
308.
Olver WJ, James SA, Lennard A et al (2002) Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients. J Hosp Infect 52:268–272PubMed
309.
Woodcock AA, Steel N, Moore CB et al (2006) Fungal contamination of bedding. Allergy 61:140–142PubMed
310.
Göttlich E, Engesser K, Bardtke D (1994) Emission von Pilzsporen in Müllverarbeitungsanlagen. Forum Städte-Hygiene 45:321–325
311.
Mahieu LM, De Dooy JJ, Laer Van FA et al (2000) A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit. J Hosp Infect 45:191–197PubMed
312.
Raad I, Hanna H, Osting CH et al (2002) Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 23:41–43PubMed
313.
(n a) (2006) Hausinstallationen, aus denen Wasser für die Öffentlichkeit bereit gestellt wird, als potenzielles Infektionsreservoir mit besonderer Berücksichtigung von Einrichtungen zur medizinischen Versorgung – Kenntnisstand, Prävention und Kontrolle – Ergebnisse einer Expertenanhörung am 31.03.2004 im Universitätsklinikum Bonn. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:681–686
314.
(n a) (2006) Hygienisch-mikrobiologische Untersuchung im Kaltwasser von Wasserversorgungsanlagen nach § 3 Nr. 2 Buchstabe c TrinkwV 2001, aus denen Wasser für die Öffentlichkeit im Sinne des § 18 Abs. 1 TrinkwV 2001 bereitgestellt wird. Empfehlung des Umweltbundesamtes nach Anhörung der Trinkwasserkommission des Bundesministeriums für Gesundheit. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:693–696
315.
(n a) (2006) Periodische Untersuchung auf Legionellen in zentralen Erwärmungsanlagen der Hausinstallation nach § 3 Nr. 2 Buchstabe c TrinkwV 2001, aus denen Wasser für die Öffentlichkeit bereit gestellt wird. Empfehlung des Umweltbundesamtes nach Anhörung der Trinkwasserkommission des Bundesministeriums für Gesundheit. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:697–700
316.
Ortolano GA, Russell RL, Angelbeck JA et al (2004) Contamination control in nursing with filtration. Part 1: filters applied to intravenous fluids and point-of-use hospital water. J Infus Nurs 27:89–103PubMed
317.
Fernandez R, Griffiths R (2008) Water for wound cleansing. Cochrane Database Syst Rev:CD003861
318.
Chaberny IF, Gastmeier P (2004) Should electronic faucets be recommended in hospitals? Infect Control Hosp Epidemiol 25:997–1000PubMed
319.
Hargreaves J, Shireley L, Hansen S et al (2001) Bacterial contamination associated with electronic faucets: a new risk for healthcare facilities. Infect Control Hosp Epidemiol 22:202–205PubMed
320.
Kommission für Krankenhaushygiene und Infektionsprävention (1999) Prävention und Kontrolle Katheter-assoziierter Harnwegsinfektionen am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 42:806–809
321.
Kommission für Krankenhaushygiene und Infektionsprävention (2007) Prävention postoperativer Infektionen im Operationsgebiet. Empfehlungen der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:377–393
322.
Chadwick PR, Beards G, Brown D et al (2000) Management of hospital outbreaks of gastro-enteritis due to small roundstructured viruses. J Hosp Infect 45:1–10PubMed
323.
Plößer P (2007) Clostridium difficile: Nachweis von Ribotyp 027 in Deutschschland – Clostridium difficile im Überblick – Hygienemaßnahmen. Hyg Med 32:403–405
324.
Robert Koch-Institut (2007) Norovirus Infektionen: Deutliche Zunahme von Gastroenteritiden. Epidemiol Bull 48:428
325.
Robert Koch-Institut (2007) RKI-Ratgeber Infektionskrankheiten „Rotaviren“ – Merkblätter für Ärzte:“Aktualisierung vom Juni 2007“. Epid Bull 10:77–79
326.
Robert Koch-Institut (2008) Clostridium difficile: Zum Stand der Meldungen schwer verlaufender Infektionen in Deutschland. Epidemiol Bull 15:117–118
327.
Schneider T, Eckmanns T, Ignatius R et al (2007) Clostridium-difficile-assoziierte Diarrhö. Dtsch Ärztebl 104:1588–1594
328.
Robert Koch-Institut Berlin (2000) Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen (§ 6 Abs. 3 und § 23 Abs. 1 und 2 in Verbindung mit § 4 Abs. 2 Nr. 2b IfSG). Rechtliche Voraussetzungen und Umsetzungsempfehlungen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 43:887–890
329.
Auletta JJ, O’Riordan MA, Nieder ML (1999) Infections in children with cancer: a continued need for the comprehensive physical examination. J Pediatr Hematol Oncol 21:501–508PubMed
330.
Simon A, Fleischhack G, Marklein G, Ritter J (2001) Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients. Klin Padiatr 213(Suppl 1):A22–A37PubMed
331.
Gorschluter M, Marklein G, Hofling K et al (2002) Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol 117:351–358PubMed
332.
Bohme A, Ruhnke M, Buchheidt D et al (2003) Treatment of fungal infections in hematology and oncology – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S133–S140PubMed
333.
Groll AH, Ritter J (2005) Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients. Klin Padiatr 217(Suppl 1):37–66
334.
Gorschluter M, Glasmacher A, Hahn C et al (2001) Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 33:786–791PubMed
335.
Neville K, Renbarger J, Dreyer Z (2002) Pneumonia in the immunocompromised pediatric cancer patient. Semin Respir Infect 17:21–32PubMed
336.
Carlisle PS, Gucalp R, Wiernik PH (1993) Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 14:320–324PubMed
337.
Dettenkofer M, Ebner W, Bertz H et al (2003) Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 31:795–801PubMed
338.
Dettenkofer M, Wenzler-Röttele S, Babikir R et al and the Hospital Infection Surveillance System for Patients with Hematologic/Oncologic Malignancies Study Group (2005) Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicener project. Clin Infect Dis 40:926–931PubMed
339.
Engelhart S, Glasmacher A, Exner M, Kramer MH (2002) Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients. Infect Control Hosp Epidemiol 23:244–248PubMed
340.
Simon A, Fleischhack G, Hasan C et al (2000) Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 21:592–596PubMed
341.
Rogers M, Weinstock DM, Eagan J et al (2000) Rotavirus outbreak on a pediatric oncology floor: possible association with toys. Am J Infect Control 28:378–380PubMed
342.
Kavaliotis J, Loukou I, Trachana M et al (1998) Outbreak of varicella in a pediatric oncology unit. Med Pediatr Oncol 31:166–169PubMed
343.
Moschovi MA, Theodoridou M, Papaevangelou V et al (2002) Outbreak of enteroviral infection in a pediatric hematology-oncology unit. Clin Infect Dis 34:1269–1272PubMed
344.
Anonymus (2005) Management of a tuberculosis exposure in an oncology hospital. Can Commun Dis Rep 31:149–156
345.
Labarca JA, Leber AL, Kern VL et al (2000) Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 30:195–197PubMed
346.
Barchiesi F, Caggiano G, Falconi Di Francesco L et al (2004) Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit. Diagn Microbiol Infect Dis 49:269–271PubMed
347.
Levin AS, Costa SF, Mussi NS et al (1998) Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis 30:243–249PubMed
348.
McAllister TA, Lucas CE, Mocan H et al (1989) Serratia marcescens outbreak in a paediatric oncology unit traced to contaminated chlorhexidine. Scott Med J 34:525–528PubMed
349.
Stephenson JR, Heard SR, Richards MA, Tabaqchali S (1985) Gastrointestinal colonization and septicaemia with Pseudomonas aeruginosa due to contaminated thymol mouthwash in immunocompromised patients. J Hosp Infect 6:369–378PubMed
350.
Aledo A, Heller G, Ren L et al (1998) Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol 20:215–221PubMed
351.
Gorelick MH, Owen WC, Seibel NL, Reaman GH (1991) Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J 10:506–510PubMedCrossRef
352.
Rahiala J, Perkkio M, Riikonen P (1998) Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients. Pediatr Hematol Oncol 15:165–174PubMed
353.
Salzer W, Steinberg SM, Liewehr DJ et al (2003) Evaluation and treatment of fever in the non-neutropenic child with cancer. J Pediatr Hematol Oncol 25:606–612PubMed
354.
Gerding DN (2004) Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 38:646–648PubMed
355.
Gerding DN, Johnson S, Peterson LR et al (1995) Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 16:459–477PubMed
356.
Hanna H, Raad I, Gonzalez V et al (2000) Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 21:226–228PubMed
357.
Johnson S, Gerding DN (1998) Clostridium difficile–associated diarrhea. Clin Infect Dis 26:1027–1034; quiz 1035–1036PubMed
358.
Paterson DL (2004) „Collateral damage“ from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis (Suppl 38) 4:S341–S345
359.
Simon A (2004) Prävention invasiver Aspergillosen bei hochgradig Immunsupprimierten onkologischen Patienten. Krankenhaushygiene und Infektionsverhütung 26:157–163
360.
Simon A, Fleischhack G (2001) Surveillance for nosocomial infections in pediatric hematology/oncology patients. Klin Padiatr 213(Suppl 1):A106–A113PubMed
361.
Simon A, Fleischhack G (2001) Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients. Klin Padiatr 213(Suppl 1)1:A9–A21PubMed
362.
Simon A, Hasan C (2003) Infektionen in der pädiatrischen Onkologie. Kinder- und Jugendmedizin 3:227–239
363.
Simon A, Beutel K, Hasan A, Bode U (2008) Evidence-based recommendation for the management of long-term central venous access devices in pediatric patients. German Society of Pediatric Hematology and Oncology (GPOH), Bonn
364.
Laws HJ, Ammann RA, Lehrnbecher T (2005) Diagnostic procedures and management of fever in pediatric cancer patients. Klin Padiatr 217:9–16
365.
Schuster FR, Laws HJ (2005) Infectious complications in the child undergoing hematopoietic stem cell transplantation. Klin Padiatr 217(Suppl 1):143–149
366.
Laws HJ, Kobbe G, Dilloo D et al (2005) Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients. J Hosp Infect 62:80–88PubMed
367.
Seifert H, Cornely O, Seggewiss K et al (2003) Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 41:118–123PubMed
368.
Beutel K, Simon A (2005) Diagnostic and management of central venous line infections in pediatric cancer patients. Klin Padiatr 217:91–100
369.
De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821
370.
Elishoov H, Or R, Strauss N, Engelhard D (1998) Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 77:83–101
371.
Cohen ML, Murphy MT, Counts GW et al (1983) Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. J Infect Dis 147:789–793PubMed
372.
Daw MA, Munnelly P, McCann SR et al (1988) Value of surveillance cultures in the management of neutropenic patients. Eur J Clin Microbiol Infect Dis 7:742–747PubMed
373.
Jong PJ de, Jong MD de, Kuijper EJ, Lelie H van der (1993) The value of surveillance cultures in neutropenic patients receiving selective intestinal decontamination. Scand J Infect Dis 25:107–113PubMed
374.
Feld R (1997) The role of surveillance cultures in patients likely to develop chemotherapy-induced mucositis. Support Care Cancer 5:371–375PubMed
375.
Glupczynski Y (2001) Usefulness of bacteriological surveillance cultures for monitoring infection in hospitalized patients: a critical reappraisal. Acta Clin Belg 56:38–45PubMed
376.
Lehrnbecher T, Laws HJ (2005) Infectious complications in pediatric cancer patients. Klin Padiatr 217:3–8
377.
Simon A, Beutel K, Marklein G, Fleischhack G (2005) Bacterial infections in pediatric cancer patients. Klin Padiatr 217:17–36
378.
Weber SG, Gold HS, Hooper DC et al (2003) Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9:1415–1422PubMed
379.
Evans ME, Titlow WB (1998) Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin. J Antimicrob Chemother 41:285–288PubMed
380.
Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49:999–1005PubMed
381.
Venezia RA, Domaracki BE, Evans AM et al (2001) Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother 48:375–381PubMed
382.
Schmidt-Hieber M, Blau IW, Schwartz S et al (2007) Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. Int J Hematol 86:158–162PubMed
383.
Worth LJ, Thursky KA, Seymour JF, Slavin MA (2007) Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 79:226–233PubMed
384.
Kommission für Krankenhaushygiene und Infektionsprävention (2004) Kommentar zu den Empfehlungen zur Prävention von Methicillin-resistenten Staphylococcus aureus Stämmen in Krankenhäusern und anderen medizinschen Einrichtungen. Epid Bull 46:396
385.
Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657–686PubMed
386.
Falagas ME, Vardakas KZ, Samonis G (2008) Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials. Curr Med Res Opin 24:215–235PubMed
387.
Kruger WH, Bohlius J, Cornely OA et al (2005) Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. Ann Oncol 16:1381–1390PubMed
388.
Chryssanthou E, Cherif H, Petrini B et al (2004) Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies. Scand J Infect Dis 36:855–859PubMed
389.
Ellis ME, Qadri SM, Spence D et al (1994) The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures. J Antimicrob Chemother 33:1223–1228PubMed
390.
Kommission für Krankenhaushygiene und Infektionsprävention (2002) Empfehlungen zum Vorgehen bei gehäuftem Auftreten von nosokomialer Infektion. Empfehlungen der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 45:180–186
391.
Kates SG, McGinley KJ, Larson EL, Leyden JJ (1991) Indigenous multiresistant bacteria from flowers in hospital and nonhospital environments. Am J Infect Control 19:156–161PubMed
392.
Mathys W, Klus K, Rehms H (1996) Erfahrungen mit dem Einsatz von Biotonnen mit Biofiltern hinsichtlich der Hygiene. In: Schriftenreihe des Arbeitskreises für die Nutzbarmachung von Siedlungsabfällen (ANS) e.V. (ed) Hygieneaspekte bei der biologischen Abfallbehandlung. p215–p231
393.
Philipp W, Haumacher R, Köhler K (1996) Keimemission aus Biotonnen in Abhängigkeit von der Abholfrequenz, dem Behältersystem und der Jahreszeit. In: Schriftenreihe des Arbeitskreises für die Nutzbarmachung von Siedlungsabfällen (ANS) e.V. (ed) Hygieneaspekte bei der biologischen Abfallbehandlung. p159–p179
394.
Oberfeld G (1996) Hygieneaspekte bei der Eigenkompostierung. In: Schriftenreihe des Arbeitskreises für die Nutzbarmachung von Siedlungsabfällen (ANS) e.V. (ed) Hygieneaspekte bei der biologischen Abfallbehandlung. p181–p213
395.
Arendrup MC, O’Driscoll BR, Petersen E, Denning DW (2006) Acute pulmonary aspergillosis in immunocompetent subjects after exposure to bark chippings. Scand J Infect Dis 38:945–949PubMed
396.
Staib F (1991) Molds in the masonry. Dtsch Med Wochenschr 116:1331PubMed
397.
Alwis KU, Mandryk J, Hocking AD (1999) Exposure to biohazards in wood dust: bacteria, fungi, endotoxins, and (1–>3)-beta-D-glucans. Appl Occup Environ Hyg 14:598–608PubMed
398.
Reiß J (1997) Schimmelpilze. Springer, Berlin Heidelberg New York
399.
Baumgardner DJ, Paretsky DP (1999) The in vitro isolation of Blastomyces dermatitidis from a woodpile in north central Wisconsin, USA. Med Mycol 37:163–168PubMed
400.
Beumer R, Bloomfield SF, Exner M et al (1998) Richtlinie zur Verhütung von Infektionen und Kreuzinfektionen im häuslichen Umfeld. Milano
401.
Kaufmann F, Engelhart S, Glasmacher A, Exner M (2002) Risk of infection and preventative strategies in the domestic environment of immunosuppressed hematologic oncology patients. Med Klin (Munich) 97:22–29
402.
Boost MV, O’Donoghue OMM, Siu KH (2007) Characterisation of methicillin-resistant Staphylococcus aureus isolates from dogs and their owners. Clin Microbiol Infect 13:731–733PubMed
403.
Herrero IA, Fernandez-Garayzabal JF, Moreno MA, Dominguez L (2004) Dogs should be included in surveillance programs for vancomycin-resistant enterococci. J Clin Microbiol 42:1384–1385PubMed
404.
Schoefer Y, Zutavern A, Brockow I et al (2008) Health risks of early swimming pool attendance. Int J Hyg Environ Health 211:367–373PubMed
405.
Barbounis V, Aperis G, Gambletsas E et al (2005) Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome. Anticancer Res 25:651–655PubMed
406.
Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62:1423–1426PubMed
407.
Worth LJ, Dooley MJ, Seymour JF et al (2005) An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer 92:867–872PubMed
408.
Dowell SF, Bresee JS (1993) Severe varicella associated with steroid use. Pediatrics 92:223–228PubMed
409.
Ahmed R, Hassall T, Morland B, Gray J (2003) Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr Hematol Oncol 20:439–444PubMed
410.
Danilatou V, Mantadakis E, Galanakis E et al (2003) Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review. Scand J Infect Dis 35:873–876PubMed
411.
Gassas A, Grant R, Richardson S et al (2004) Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol 22:1222–1227PubMed
412.
Lyytikainen O, Rautio M, Carlson P et al (2004) Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance. J Antimicrob Chemother 53:631–634PubMed
413.
Okamoto Y, Ribeiro RC, Srivastava DK et al (2003) Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. J Pediatr Hematol Oncol 25:696–703PubMed
414.
Paganini H, Staffolani V, Zubizarreta P et al (2003) Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer 39:1284–1289PubMed
415.
Tunkel AR, Sepkowitz KA (2002) Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34:1524–1529PubMed
416.
Anaissie EJ, Kontoyiannis DP, O’Brien S et al (1998) Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 129:559–566PubMed
417.
Hendrick A (2001) Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia. J Clin Pathol 54:412–413PubMed
418.
Ng HJ, Lim LC (2001) Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. Ann Hematol 80:549–552PubMed
419.
Tsutsumi Y, Kanamori H, Mori A et al (2005) Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 4:599–608PubMed
420.
Westhoff TH, Jochimsen F, Schmittel A et al (2003) Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930PubMed
421.
Clave E, Agbalika F, Bajzik V et al (2004) Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. Transplantation 77:76–84PubMed
422.
Nguyen DD, Cao TM, Dugan K et al (2002) Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia. Clin Lymphoma 3:105–110PubMed
423.
Gea-Banacloche JC, Opal SM, Jorgensen J et al (2004) Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med 32:S578–590PubMed
424.
Winthrop KL (2006) Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2:602–610PubMed
425.
Dixon WG, Watson K, Lunt M et al (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54:2368–2376PubMed
426.
Michel BA, Hunder GG, Bloch DA, Calabrese LH (1992) Hypersensitivity vasculitis and Henoch-Schonlein purpura: a comparison between the 2 disorders. J Rheumatol 19:721–728PubMed
Metadaten
Titel
Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten
Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI)
verfasst von
Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI)
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz / Ausgabe 4/2010
Print ISSN: 1436-9990
Elektronische ISSN: 1437-1588
DOI
https://doi.org/10.1007/s00103-010-1028-9

Weitere Artikel der Ausgabe 4/2010

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 4/2010 Zur Ausgabe

Leitthema

Pathologisches Glücksspiel und Computerspielabhängigkeit

Leitthema

Pathologisches Kaufen

Leitthema

Was verstehen wir unter Sucht?

Leitthema

Zusammenhang zwischen Verschreibungsverhalten der Ärzte und Medikamentenabhängigkeit ihrer Patienten

Leitthema

Bildgebung in der Diagnostik der Alkoholabhängigkeit

Leitthema

Die Förderung von Resilienz und Schutzfaktoren bei Kindern suchtkranker Eltern

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Neu im Fachgebiet Allgemeinmedizin

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz

17.04.2024 | DGIM 2024 | Nachrichten

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

17.04.2024 | Delir nicht substanzbedingt | Nachrichten

Delir kann Demenz begünstigen
weitere anzeigen

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise